HEPATITIS D, CHRONIC

Clinical trials for HEPATITIS D, CHRONIC explained in plain language.

Never miss a new study

Get alerted when new HEPATITIS D, CHRONIC trials appear

Sign up with your email to follow new studies for HEPATITIS D, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New hope for rare liver disease: phase 3 trial of hepalatide begins

Disease control Not yet recruiting

This study tests a new drug called hepalatide (L47) in 150 adults with chronic hepatitis D, a serious liver infection. Participants are randomly assigned to receive either hepalatide or a placebo daily for 48 weeks, followed by an optional open-label phase. The goal is to see if …

Matched conditions: HEPATITIS D, CHRONIC

Phase: PHASE3 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 17, 2026 12:25 UTC

HEPATITIS D, CHRONIC

Get alerted when new HEPATITIS D, CHRONIC trials appear

New hope for rare liver disease: phase 3 trial of hepalatide begins